{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:34:04Z","timestamp":1790685244239,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"am","delay-in-days":382,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.therap.2021.06.003","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T22:26:23Z","timestamp":1623968783000},"page":"629-637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting of under-75 years for the optimization of medication reconciliation with an approach based on medication risks: An observational study"],"prefix":"10.1016","volume":"76","author":[{"given":"Justine","family":"Perino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Gouverneur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin","family":"Lahouati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblle","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Breilh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Xuereb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2021.06.003_bib0115","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1345\/aph.1L045","article-title":"Assessment of clinical pharmacists\u2019 interventions in French hospitals: results of a multicenter study","volume":"42","author":"Bedouch","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.therap.2021.06.003_bib0120","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s11096-013-9824-6","article-title":"Pharmacist-led medication reconciliation to reduce discrepancies in transitions of care in Spain","volume":"35","author":"Allende Bandr\u00e9s M\u00c1","year":"2013","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.therap.2021.06.003_bib0125","first-page":"105","article-title":"Impact of a pharmacy-led medication reconciliation program","volume":"43","author":"Digiantonio","year":"2018","journal-title":"P T."},{"key":"10.1016\/j.therap.2021.06.003_bib0130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/jgs.15195","article-title":"Meta-analysis of interventions to reduce adverse drug reactions in older adults","volume":"66","author":"Gray","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.therap.2021.06.003_bib0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13690-015-0095-7","article-title":"Factors associated with excessive polypharmacy in older people","volume":"73","author":"Walckiers","year":"2015","journal-title":"Arch Public Health"},{"key":"10.1016\/j.therap.2021.06.003_bib0140","doi-asserted-by":"crossref","first-page":"e010568","DOI":"10.1136\/bmjopen-2015-010568","article-title":"Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients","volume":"7","author":"Kiguba","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.therap.2021.06.003_bib0145","series-title":"Mettre en \u0153uvre la conciliation des traitements m\u00e9dicamenteux en \u00e9tablissement de sant\u00e9 guide m\u00e9thodologique","author":"Haute autorit\u00e9 de sant\u00e9","year":"2018"},{"key":"10.1016\/j.therap.2021.06.003_bib0150","series-title":"Initiative des HIGH 5s Medication Reconciliation - Annexe 5","author":"Haute autorit\u00e9 de sant\u00e9","year":"2015"},{"key":"10.1016\/j.therap.2021.06.003_bib0155","series-title":"Effets ind\u00e9sirables graves li\u00e9s au medicament en Nouvelle-Aquitaine","author":"R\u00e9seau r\u00e9gional de vigilances et d\u2019appui de Nouvelle-Aquitaine","year":"2018"},{"key":"10.1016\/j.therap.2021.06.003_bib0160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.therap.2019.09.004","article-title":"Pharmacovigilance: the next chapter","volume":"74","author":"Moore","year":"2019","journal-title":"Therapies"},{"key":"10.1016\/j.therap.2021.06.003_bib0165","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.therap.2016.06.002","article-title":"Targeting high-risk drugs to optimize clinical pharmacists\u2019 intervention","volume":"71","author":"Mouterde","year":"2016","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2021.06.003_bib0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.therap.2021.06.003_bib0175","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.amjopharm.2012.08.001","article-title":"Medication discrepancy and potentially inappropriate medication in older Chinese-American home-care patients after hospital discharge","volume":"10","author":"Hu","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.therap.2021.06.003_bib0180","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/bmjqs-2012-001769","article-title":"Promoting engagement by patients and families to reduce adverse events in acute care settings: a systematic review","volume":"23","author":"Berger","year":"2014","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.therap.2021.06.003_bib0185","first-page":"37","article-title":"La communication ville-h\u00f4pital: un mod\u00e8le pour am\u00e9liorer la continuit\u00e9 des soins","volume":"2","author":"Alao","year":"2001","journal-title":"Les Cahiers du num\u00e9rique"},{"key":"10.1016\/j.therap.2021.06.003_bib0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/amiajnl-2014-002760","article-title":"HITEC investigators. The potential for community-based health information exchange systems to reduce hospital readmissions","volume":"22","author":"Vest","year":"2015","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.therap.2021.06.003_bib0195","series-title":"Le dossier pharmaceutique. Qu\u2019est-ce que le DP\u202f?","author":"Ordre national des pharmaciens","year":"2019"},{"key":"10.1016\/j.therap.2021.06.003_bib0200","doi-asserted-by":"crossref","first-page":"198603","DOI":"10.1155\/2014\/198603","article-title":"Prevalence of frailty indicators and association with socioeconomic status in middle-aged and older adults in a swiss region with universal health insurance coverage: a population-based cross-sectional study","volume":"2014","author":"Guessous","year":"2014","journal-title":"J Aging Res"},{"issue":"7","key":"10.1016\/j.therap.2021.06.003_bib0205","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2468-2667(18)30091-4","article-title":"Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493\u2008737 UK Biobank participants","volume":"3","author":"Hanlon","year":"2018","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.therap.2021.06.003_bib0210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11096-017-0581-9","article-title":"The scope of drug-related problems in the home care setting","volume":"40","author":"Meyer-Massetti","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"Suppl 3","key":"10.1016\/j.therap.2021.06.003_bib0215","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.2146\/ajhp150381","article-title":"Interventions unrelated to anticoagulation in a pharmacist-managed anticoagulation clinic","volume":"73","author":"Hicho","year":"2016","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.therap.2021.06.003_bib0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11096-014-0047-2","article-title":"Reducing medication errors at admission: 3 cycles to implement, improve and sustain medication reconciliation","volume":"37","author":"Curatolo","year":"2015","journal-title":"Int J Clin Pharm"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595721001517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595721001517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:55:50Z","timestamp":1758567350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595721001517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0040595721001517"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2021.06.003","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting of under-75 years for the optimization of medication reconciliation with an approach based on medication risks: An observational study","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2021.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}